High Free Cash Flow Stocks
NVST is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
ENVISTA HOLDINGS CORP (NVST) Stock Price & Overview
NYSE:NVST • US29415F1049
Current stock price
27.14 USD
-0.06 (-0.22%)
At close:
27.52 USD
+0.38 (+1.4%)
After Hours:
The current stock price of NVST is 27.14 USD. Today NVST is down by -0.22%. In the past month the price increased by 4.26%. In the past year, price increased by 70.26%.
NVST Key Statistics
52-Week Range15.49 - 30.4199
Current NVST stock price positioned within its 52-week range.
1-Month Range24.17 - 28.53
Current NVST stock price positioned within its 1-month range.
- Market Cap
- 4.423B
- P/E
- 22.62
- Fwd P/E
- 18.87
- EPS (TTM)
- 1.20
- Dividend Yield
- N/A
NVST Stock Performance
Today
-0.22%
1 Week
+0.41%
1 Month
+4.26%
3 Months
+13.84%
Longer-term
6 Months +33.30%
1 Year +70.26%
2 Years +37.91%
3 Years -29.49%
5 Years -37.29%
10 Years N/A
NVST Stock Chart
NVST Stock Screens
NVST currently appears in the following ChartMill screener lists.
NVST Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to NVST. When comparing the yearly performance of all stocks, NVST is one of the better performing stocks in the market, outperforming 87.67% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
NVST Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NVST. NVST has only an average score on both its financial health and profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NVST Earnings
On February 5, 2026 NVST reported an EPS of 0.38 and a revenue of 750.60M. The company beat EPS expectations (15.44% surprise) and beat revenue expectations (8.23% surprise).
Next Earnings DateMay 6, 2026
Last Earnings DateFeb 5, 2026
PeriodQ4 / 2025
EPS Reported$0.38
Revenue Reported750.6M
EPS Surprise 15.44%
Revenue Surprise 8.23%
NVST Forecast & Estimates
20 analysts have analysed NVST and the average price target is 29.49 USD. This implies a price increase of 8.65% is expected in the next year compared to the current price of 27.14.
For the next year, analysts expect an EPS growth of 19.87% and a revenue growth 7.6% for NVST
Analysts
Analysts79
Price Target29.49 (8.66%)
EPS Next Y19.87%
Revenue Next Year7.6%
NVST Groups
Sector & Classification
NVST Financial Highlights
Over the last trailing twelve months NVST reported a non-GAAP Earnings per Share(EPS) of 1.2. The EPS increased by 64.38% compared to the year before.
Income Statements
Revenue(TTM)2.72B
Net Income(TTM)47.00M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.73% | ||
| ROA | 0.83% | ||
| ROE | 1.51% | ||
| Debt/Equity | 0.47 |
Chartmill High Growth Momentum
EPS Q2Q%58.33%
Sales Q2Q%14.96%
EPS 1Y (TTM)64.38%
Revenue 1Y (TTM)8.32%
NVST Ownership
Ownership
Inst Owners112.74%
Shares162.98M
Float161.50M
Ins Owners0.42%
Short Float %5.97%
Short Ratio3.27
NVST Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 41.46 | 171.767B | ||
| ABT | ABBOTT LABORATORIES | 14.59 | 159.344B | ||
| SYK | STRYKER CORP | 21.78 | 126.134B | ||
| BSX | BOSTON SCIENTIFIC CORP | 16.43 | 96.409B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.06 | 47.005B | ||
| IDXX | IDEXX LABORATORIES INC | 39.06 | 45.933B | ||
| BDX | BECTON DICKINSON AND CO | 11.4 | 44.32B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.81 | 32.57B | ||
| RMD | RESMED INC | 18.08 | 32.347B | ||
| DXCM | DEXCOM INC | 24.93 | 24.404B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.97 | 18.01B | ||
| PODD | INSULET CORP | 29.86 | 13.41B | ||
| PEN | PENUMBRA INC | 65.18 | 13.063B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NVST
Company Profile
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,000 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Company Info
IPO: 2019-09-18
ENVISTA HOLDINGS CORP
200 S. Kraemer Blvd., Bldg. E
Brea CALIFORNIA 92821 US
CEO: Amir Aghdaei
Employees: 12000
Phone: 17148175418
ENVISTA HOLDINGS CORP / NVST FAQ
What does NVST do?
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,000 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
What is the stock price of ENVISTA HOLDINGS CORP today?
The current stock price of NVST is 27.14 USD. The price decreased by -0.22% in the last trading session.
Does ENVISTA HOLDINGS CORP pay dividends?
NVST does not pay a dividend.
How is the ChartMill rating for ENVISTA HOLDINGS CORP?
NVST has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the growth outlook for ENVISTA HOLDINGS CORP?
The Revenue of ENVISTA HOLDINGS CORP (NVST) is expected to grow by 7.6% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the upcoming earnings date for ENVISTA HOLDINGS CORP?
ENVISTA HOLDINGS CORP (NVST) will report earnings on 2026-05-06, after the market close.
What is the Short Interest ratio of ENVISTA HOLDINGS CORP (NVST) stock?
The outstanding short interest for ENVISTA HOLDINGS CORP (NVST) is 5.97% of its float.